Save your place

Sign in to WhoBought

Please try again later.

Galectin Therapeutics Inc. (GALT) institutional ownership

Latest close $3.85 Jul 21, 2026
Market cap$231M 52-week range SectorHealthcare
Funds holding · Q1 2026
85
reported GALT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
47 buyers · 38 sellers

Galectin Therapeutics Inc. (GALT) price and institutional activity

Dates

Q1 2026

$0 bought by 47 investors
Marshall Wace, LLPMillennium Management LLC +45 more
$0 sold by 38 investors
Morgan StanleyWellington Management Group LLP +36 more
Bought Sold Totals per quarter; hover a bar for the names.

Galectin Therapeutics Inc. (GALT) institutional activity · 85

Investor Type Est. change Change Δ Own Date
Marshall Wace, LLP · Added
Change +618K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +618K Q1 2026
Millennium Management LLC · Added
Change +563K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +563K Q1 2026
Two Sigma Investments, LP · Added
Change +450K Δ Own +2711.6% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +450K +2711.6% Q1 2026
Citadel Advisors LLC New· Q1 2026 +290K Q1 2026
Susquehanna International Group, LLP · Added
Change +269K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +269K Q1 2026
Morgan Stanley · Reduced
Change −175K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −175K Q1 2026
Renaissance Technologies LLC New· Q1 2026 +148K Q1 2026
Wellington Management Group LLP · Exited
Change −142K Δ Own −100.0% Date Q1 2026
Wellington Management Group LLP Exited· Q1 2026 −142K −100.0% Q1 2026
UBS Group AG · Added
Change +141K Date Q1 2026
UBS Group AG Added· Q1 2026 +141K Q1 2026
Goldman Sachs Group Inc · Reduced
Change −122K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −122K Q1 2026
Wealthspire Advisors, LLC · Added
Change +120K Date Q1 2026
Wealthspire Advisors, LLC Added· Q1 2026 +120K Q1 2026
Blair William & Co · Added
Change +111K Date Q1 2026
Blair William & Co Added· Q1 2026 +111K Q1 2026
Traynor Capital Management, Inc. · Exited
Change −102K Δ Own −100.0% Date Q1 2026
Traynor Capital Management, Inc. Exited· Q1 2026 −102K −100.0% Q1 2026
Exoduspoint Capital Management, LP · Exited
Change −82K Δ Own −100.0% Date Q1 2026
Exoduspoint Capital Management, LP Exited· Q1 2026 −82K −100.0% Q1 2026
Simplex Trading, LLC · Added
Change +78K Date Q1 2026
Simplex Trading, LLC Added· Q1 2026 +78K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 85

Famous investor activity in Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Inc. (GALT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Jamil Khurram · Officer Sell −$83K
Price $5.13 Qty −16K Owned 0 ΔOwn −100.0% Trade date Jul 14, 2026 Filed date Jul 16, 2026
Jamil Khurram Officer Sell $5.13 −16K −$83K 0 −100.0% Jul 14, 2026 Jul 16, 2026
Jamil Khurram · Officer 2 operations 0
Price $3.04 Owned 49K Trade date Jul 14, 2026 Filed date Jul 16, 2026
Jamil Khurram Officer 2 operations $3.04 0 49K Jul 14, 2026 Jul 16, 2026
Shlevin Harold H. · Director Sell −$112K
Price $5.04 Qty −22K Owned 6K ΔOwn −77.4% Trade date Jun 29, 2026 Filed date Jun 30, 2026
Shlevin Harold H. Director Sell $5.04 −22K −$112K 6K −77.4% Jun 29, 2026 Jun 30, 2026
Shlevin Harold H. · Director 2 operations 0
Price $1.23 Owned 30K Trade date Jun 29, 2026 Filed date Jun 30, 2026
Shlevin Harold H. Director 2 operations $1.23 0 30K Jun 29, 2026 Jun 30, 2026
Jamil Khurram · Officer Sell −$239K
Price $5.04 Qty −47K Owned 0 ΔOwn −100.0% Trade date Jun 29, 2026 Filed date Jun 30, 2026
Jamil Khurram Officer Sell $5.04 −47K −$239K 0 −100.0% Jun 29, 2026 Jun 30, 2026
Jamil Khurram · Officer 2 operations 0
Price $2.50 Owned 0 Trade date Jun 29, 2026 Filed date Jun 30, 2026
Jamil Khurram Officer 2 operations $2.50 0 0 Jun 29, 2026 Jun 30, 2026
Shlevin Harold H. · Director Sell −$39K
Price $5.00 Qty −8K Owned 6K ΔOwn −54.3% Trade date Jun 26, 2026 Filed date Jun 30, 2026
Shlevin Harold H. Director Sell $5.00 −8K −$39K 6K −54.3% Jun 26, 2026 Jun 30, 2026
Shlevin Harold H. · Director 2 operations 0
Price $1.23 Owned 52K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Shlevin Harold H. Director 2 operations $1.23 0 52K Jun 26, 2026 Jun 30, 2026
Jamil Khurram · Officer 2 operations −$23K
Price $5.00 Qty −5K Owned 0 Trade date Jun 26, 2026 Filed date Jun 30, 2026
Jamil Khurram Officer 2 operations $5.00 −5K −$23K 0 Jun 26, 2026 Jun 30, 2026
Jamil Khurram · Officer 4 operations 0
Price $2.20–$2.50 Owned 47K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Jamil Khurram Officer 4 operations $2.20–$2.50 0 47K Jun 26, 2026 Jun 30, 2026
Jamil Khurram · Officer Sell −$24K
Price $3.14 Qty −8K Owned 0 ΔOwn −100.0% Trade date Jun 23, 2026 Filed date Jun 25, 2026
Jamil Khurram Officer Sell $3.14 −8K −$24K 0 −100.0% Jun 23, 2026 Jun 25, 2026
Jamil Khurram · Officer 2 operations 0
Price $1.23 Owned 32K Trade date Jun 23, 2026 Filed date Jun 25, 2026
Jamil Khurram Officer 2 operations $1.23 0 32K Jun 23, 2026 Jun 25, 2026
Jamil Khurram · Officer Sell −$2K
Price $3.10 Qty −568 Owned 0 Trade date May 26, 2026 Filed date May 28, 2026
Jamil Khurram Officer Sell $3.10 −568 −$2K 0 May 26, 2026 May 28, 2026
Jamil Khurram · Officer 2 operations 0
Price $1.23 Owned 40K Trade date May 26, 2026 Filed date May 28, 2026
Jamil Khurram Officer 2 operations $1.23 0 40K May 26, 2026 May 28, 2026
Brem Henry · Director Grant (A) 60K
Owned 60K Trade date Mar 12, 2026 Filed date Mar 17, 2026
Brem Henry Director Grant (A) 60K 60K Mar 12, 2026 Mar 17, 2026
15 of 97
15 of 97 Sign in to continue to older insider transactions.

Galectin Therapeutics Inc. (GALT) activist and large shareholders

Dates
No Schedule 13D or 13G filing is available for GALT in this range.

Galectin Therapeutics Inc. (GALT) ownership FAQ

Who owns GALT?

85 reporting institutions disclosed GALT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.